home / stock / canf / canf short
Short Information | Can-Fite Biopharma Ltd Sponsored ADR (NYSE:CANF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 53,171 |
Total Actual Volume | 2,749,827 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 2,659 |
Average Short Percentage | 1.30% |
Is there a CANF Short Squeeze or Breakout about to happen?
See the CANF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $2.73 | $2.4 | $2.73 | $2.3 | 93,419 | 577 | 0.62% |
07-01-2024 | $2.66 | $2.61 | $2.7079 | $2.55 | 41,943 | 534 | 1.27% |
06-28-2024 | $2.6 | $2.58 | $2.69 | $2.55 | 89,798 | 1,833 | 2.04% |
06-27-2024 | $2.67 | $2.56 | $2.7399 | $2.55 | 46,750 | 701 | 1.5% |
06-26-2024 | $2.81 | $2.65 | $2.8399 | $2.61 | 62,754 | 2,017 | 3.21% |
06-25-2024 | $2.91 | $2.84 | $3.02 | $2.7501 | 65,632 | 1,034 | 1.58% |
06-24-2024 | $2.94 | $2.87 | $2.9699 | $2.76 | 63,764 | 510 | 0.8% |
06-21-2024 | $2.77 | $2.725 | $2.78 | $2.62 | 39,842 | 171 | 0.43% |
06-20-2024 | $2.72 | $2.71 | $2.84 | $2.6501 | 64,288 | 1,634 | 2.54% |
06-18-2024 | $3 | $2.73 | $3.055 | $2.61 | 208,733 | 6,717 | 3.22% |
06-17-2024 | $3.36 | $3.21 | $3.36 | $3.2 | 134,508 | 901 | 0.67% |
06-14-2024 | $3.76 | $3.35 | $4.48 | $3.1 | 677,332 | 27,944 | 4.13% |
06-13-2024 | $3.1 | $3.63 | $3.85 | $3 | 298,360 | 2,083 | 0.7% |
06-12-2024 | $2.83 | $3.14 | $3.3 | $2.83 | 335,112 | 4,507 | 1.34% |
06-11-2024 | $2.55 | $2.76 | $2.8452 | $2.52 | 141,084 | 1,451 | 1.03% |
06-10-2024 | $2.5 | $2.53 | $2.59 | $2.41 | 64,601 | 4 | 0.01% |
06-07-2024 | $2.51 | $2.47 | $2.56 | $2.4 | 39,843 | 15 | 0.04% |
06-06-2024 | $2.54 | $2.5566 | $2.59 | $2.35 | 61,163 | 523 | 0.86% |
06-05-2024 | $2.6 | $2.57 | $2.66 | $2.5 | 117,982 | 5 | 0% |
06-04-2024 | $2.38 | $2.67 | $2.72 | $2.31 | 102,919 | 10 | 0.01% |
News, Short Squeeze, Breakout and More Instantly...
Can-Fite Biopharma Ltd Sponsored ADR Company Name:
CANF Stock Symbol:
NYSE Market:
Can-Fite Biopharma Ltd Sponsored ADR Website:
Liver cirrhosis treatment global market is estimated to reach $29.2 billion by 2030 Ramat Gan, Israel, July 01, 2024 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that addr...
The canine osteoarthritis market is projected to reach $3 billion by 2028 Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced ...
Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announces that company scientists came up with breakthrough findings showing that the anti-cance...